olps Search Results


90
Proimmune hbv-specific genotype d overlapping peptides (olps)
<t>HBV-specific</t> CD4 + and CD8 + T cell responses in different age groups. HBV-specific CD4 + and CD8 + T cell responses following 10-day in vitro stimulation with HBV overlapping peptide (OLP) pools grouped according to the patients’ age. (A) Representative flow cytometry plots of HBV core-specific IFN-γ + /TNF + CD4 + T cell responses of two patients. (B) Heat map showing mean of frequencies of total cytokine + HBV-specific CD4 + and CD8 + T cells (age groups: 18–39, n=25; 40–49, n=17; ≥50, n=15). (C) IFN-γ + HBV-specific CD4 + and CD8 + T cells of different age groups. (D) Correlation analyses of age with frequencies of total IFN-γ + CD4 + and CD8 + T cells. (E) Mean percentages of multifunctional CD4 + and CD8 + T cell responses after in vitro expansion with total HBV <t>OLPs</t> (sum of 14 OLP pools). Statistical significance between each of the two groups was tested by Mann-Whitney test for non-parametric data and by unpaired t-test for parametric data (B–C). *p<0.05; **p<0.01. IFN, interferon; TNF, tumour necrosis factor.
Hbv Specific Genotype D Overlapping Peptides (Olps), supplied by Proimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/olps/hbv+specific+genotype+d+overlapping+peptides++olps+/pmc09554084-61-4-6
Average 90 stars, based on 1 article reviews
hbv-specific genotype d overlapping peptides (olps) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Proimmune hbv core overlapping peptides (olps) genotype d
<t>HBV-specific</t> CD4 + and CD8 + T cell responses in different age groups. HBV-specific CD4 + and CD8 + T cell responses following 10-day in vitro stimulation with HBV overlapping peptide (OLP) pools grouped according to the patients’ age. (A) Representative flow cytometry plots of HBV core-specific IFN-γ + /TNF + CD4 + T cell responses of two patients. (B) Heat map showing mean of frequencies of total cytokine + HBV-specific CD4 + and CD8 + T cells (age groups: 18–39, n=25; 40–49, n=17; ≥50, n=15). (C) IFN-γ + HBV-specific CD4 + and CD8 + T cells of different age groups. (D) Correlation analyses of age with frequencies of total IFN-γ + CD4 + and CD8 + T cells. (E) Mean percentages of multifunctional CD4 + and CD8 + T cell responses after in vitro expansion with total HBV <t>OLPs</t> (sum of 14 OLP pools). Statistical significance between each of the two groups was tested by Mann-Whitney test for non-parametric data and by unpaired t-test for parametric data (B–C). *p<0.05; **p<0.01. IFN, interferon; TNF, tumour necrosis factor.
Hbv Core Overlapping Peptides (Olps) Genotype D, supplied by Proimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/olps/hbv+core+overlapping+peptides++olps++genotype+d/pmc06773856-106-26-30
Average 90 stars, based on 1 article reviews
hbv core overlapping peptides (olps) genotype d - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Dawley Inc primary cultures of olps
<t>HBV-specific</t> CD4 + and CD8 + T cell responses in different age groups. HBV-specific CD4 + and CD8 + T cell responses following 10-day in vitro stimulation with HBV overlapping peptide (OLP) pools grouped according to the patients’ age. (A) Representative flow cytometry plots of HBV core-specific IFN-γ + /TNF + CD4 + T cell responses of two patients. (B) Heat map showing mean of frequencies of total cytokine + HBV-specific CD4 + and CD8 + T cells (age groups: 18–39, n=25; 40–49, n=17; ≥50, n=15). (C) IFN-γ + HBV-specific CD4 + and CD8 + T cells of different age groups. (D) Correlation analyses of age with frequencies of total IFN-γ + CD4 + and CD8 + T cells. (E) Mean percentages of multifunctional CD4 + and CD8 + T cell responses after in vitro expansion with total HBV <t>OLPs</t> (sum of 14 OLP pools). Statistical significance between each of the two groups was tested by Mann-Whitney test for non-parametric data and by unpaired t-test for parametric data (B–C). *p<0.05; **p<0.01. IFN, interferon; TNF, tumour necrosis factor.
Primary Cultures Of Olps, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/olps/primary+cultures+of+olps/pm27797401-39-4-8
Average 90 stars, based on 1 article reviews
primary cultures of olps - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Mimotopes overlapping hcv peptides (olps)
Matrix approach for epitope mapping. In this case, each matrix pool (A to J and AA to JJ) consists of five <t>HCV</t> <t>overlapping</t> <t>peptides.</t> A specific peptide is included in only one of the horizontal matrix pools (A to J) and only one of the vertical matrix pools (AA to JJ). Therefore, if pools D and CC yield positive responses, peptide 24 triggered the response. If pools C, D, E, and CC induce formation of a significant number of spots in the ELISpot assay, the responsible epitope probably consists of the shared sequence of peptides 23, 24 and 25 (fcsamyvgdl).
Overlapping Hcv Peptides (Olps), supplied by Mimotopes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/olps/overlapping+hcv+peptides++olps+/pmc06886882-90-1-20
Average 90 stars, based on 1 article reviews
overlapping hcv peptides (olps) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Genaxxon BioScience GmbH overlapping peptides (olps)
Matrix approach for epitope mapping. In this case, each matrix pool (A to J and AA to JJ) consists of five <t>HCV</t> <t>overlapping</t> <t>peptides.</t> A specific peptide is included in only one of the horizontal matrix pools (A to J) and only one of the vertical matrix pools (AA to JJ). Therefore, if pools D and CC yield positive responses, peptide 24 triggered the response. If pools C, D, E, and CC induce formation of a significant number of spots in the ELISpot assay, the responsible epitope probably consists of the shared sequence of peptides 23, 24 and 25 (fcsamyvgdl).
Overlapping Peptides (Olps), supplied by Genaxxon BioScience GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/olps/overlapping+peptides++olps+/pmc10019593__mmc1-5-17-62
Average 90 stars, based on 1 article reviews
overlapping peptides (olps) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Mimotopes overlapping hivp24 peptides (olps)
(A) Breadth of T-cell responses against 23 <t>HIVp24-specific</t> OLPs from VC (N = 19, filled circle) and NC (N = 42, open rectangle) (B) Breadth of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle) (C) Cumulative magnitude of T-cell responses against 23 HIVp24-specific OLPs in VC (N = 19, filled circle) and NC (N = 42, open rectangle) (D) Cumulative magnitude of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle). (E and F) Correlation between breadth and cumulative magnitude of T-cell responses against HIVp24-specific OLPs and patient pVL were analyzed by using Spearman’s rank test.
Overlapping Hivp24 Peptides (Olps), supplied by Mimotopes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/olps/hivp24+peptides++olps+/pmc04357381-52-2-36
Average 90 stars, based on 1 article reviews
overlapping hivp24 peptides (olps) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
GenScript corporation olps
(A) Breadth of T-cell responses against 23 <t>HIVp24-specific</t> OLPs from VC (N = 19, filled circle) and NC (N = 42, open rectangle) (B) Breadth of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle) (C) Cumulative magnitude of T-cell responses against 23 HIVp24-specific OLPs in VC (N = 19, filled circle) and NC (N = 42, open rectangle) (D) Cumulative magnitude of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle). (E and F) Correlation between breadth and cumulative magnitude of T-cell responses against HIVp24-specific OLPs and patient pVL were analyzed by using Spearman’s rank test.
Olps, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/olps/olps/pm39972124-517-3-5
Average 90 stars, based on 1 article reviews
olps - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
The Company of Biologists pdgfra-positive presumptive oligodendrocyte progenitors (olps)
(A) Breadth of T-cell responses against 23 <t>HIVp24-specific</t> OLPs from VC (N = 19, filled circle) and NC (N = 42, open rectangle) (B) Breadth of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle) (C) Cumulative magnitude of T-cell responses against 23 HIVp24-specific OLPs in VC (N = 19, filled circle) and NC (N = 42, open rectangle) (D) Cumulative magnitude of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle). (E and F) Correlation between breadth and cumulative magnitude of T-cell responses against HIVp24-specific OLPs and patient pVL were analyzed by using Spearman’s rank test.
Pdgfra Positive Presumptive Oligodendrocyte Progenitors (Olps), supplied by The Company of Biologists, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/olps/pdgfra+positive+presumptive+oligodendrocyte+progenitors++olps+/pm11493571-6-11-39
Average 90 stars, based on 1 article reviews
pdgfra-positive presumptive oligodendrocyte progenitors (olps) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
The Company of Biologists olps
(A) Breadth of T-cell responses against 23 <t>HIVp24-specific</t> OLPs from VC (N = 19, filled circle) and NC (N = 42, open rectangle) (B) Breadth of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle) (C) Cumulative magnitude of T-cell responses against 23 HIVp24-specific OLPs in VC (N = 19, filled circle) and NC (N = 42, open rectangle) (D) Cumulative magnitude of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle). (E and F) Correlation between breadth and cumulative magnitude of T-cell responses against HIVp24-specific OLPs and patient pVL were analyzed by using Spearman’s rank test.
Olps, supplied by The Company of Biologists, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/olps/olps/pm12399304-11-13-39
Average 90 stars, based on 1 article reviews
olps - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
GenScript corporation 11–15-mer synthetic olps corresponding to each 25-mer neoantigen vaccine peptide
(A) Breadth of T-cell responses against 23 <t>HIVp24-specific</t> OLPs from VC (N = 19, filled circle) and NC (N = 42, open rectangle) (B) Breadth of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle) (C) Cumulative magnitude of T-cell responses against 23 HIVp24-specific OLPs in VC (N = 19, filled circle) and NC (N = 42, open rectangle) (D) Cumulative magnitude of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle). (E and F) Correlation between breadth and cumulative magnitude of T-cell responses against HIVp24-specific OLPs and patient pVL were analyzed by using Spearman’s rank test.
11–15 Mer Synthetic Olps Corresponding To Each 25 Mer Neoantigen Vaccine Peptide, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/olps/11+15+mer+synthetic+olps+corresponding+to+each+25+mer+neoantigen+vaccine+peptide/pm40346292-211-9-12
Average 90 stars, based on 1 article reviews
11–15-mer synthetic olps corresponding to each 25-mer neoantigen vaccine peptide - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


HBV-specific CD4 + and CD8 + T cell responses in different age groups. HBV-specific CD4 + and CD8 + T cell responses following 10-day in vitro stimulation with HBV overlapping peptide (OLP) pools grouped according to the patients’ age. (A) Representative flow cytometry plots of HBV core-specific IFN-γ + /TNF + CD4 + T cell responses of two patients. (B) Heat map showing mean of frequencies of total cytokine + HBV-specific CD4 + and CD8 + T cells (age groups: 18–39, n=25; 40–49, n=17; ≥50, n=15). (C) IFN-γ + HBV-specific CD4 + and CD8 + T cells of different age groups. (D) Correlation analyses of age with frequencies of total IFN-γ + CD4 + and CD8 + T cells. (E) Mean percentages of multifunctional CD4 + and CD8 + T cell responses after in vitro expansion with total HBV OLPs (sum of 14 OLP pools). Statistical significance between each of the two groups was tested by Mann-Whitney test for non-parametric data and by unpaired t-test for parametric data (B–C). *p<0.05; **p<0.01. IFN, interferon; TNF, tumour necrosis factor.

Journal: Gut

Article Title: Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection

doi: 10.1136/gutjnl-2021-324646

Figure Lengend Snippet: HBV-specific CD4 + and CD8 + T cell responses in different age groups. HBV-specific CD4 + and CD8 + T cell responses following 10-day in vitro stimulation with HBV overlapping peptide (OLP) pools grouped according to the patients’ age. (A) Representative flow cytometry plots of HBV core-specific IFN-γ + /TNF + CD4 + T cell responses of two patients. (B) Heat map showing mean of frequencies of total cytokine + HBV-specific CD4 + and CD8 + T cells (age groups: 18–39, n=25; 40–49, n=17; ≥50, n=15). (C) IFN-γ + HBV-specific CD4 + and CD8 + T cells of different age groups. (D) Correlation analyses of age with frequencies of total IFN-γ + CD4 + and CD8 + T cells. (E) Mean percentages of multifunctional CD4 + and CD8 + T cell responses after in vitro expansion with total HBV OLPs (sum of 14 OLP pools). Statistical significance between each of the two groups was tested by Mann-Whitney test for non-parametric data and by unpaired t-test for parametric data (B–C). *p<0.05; **p<0.01. IFN, interferon; TNF, tumour necrosis factor.

Article Snippet: HBV-specific genotype D overlapping peptides (OLPs) (ProImmune, Oxford, UK) were made up of 15 amino acids, overlapped by 10 amino acids, spanned the entire HBV core (two pools), surface (four pools) and polymerase (eight pools) ( ).

Techniques: In Vitro, Flow Cytometry, MANN-WHITNEY

Matrix approach for epitope mapping. In this case, each matrix pool (A to J and AA to JJ) consists of five HCV overlapping peptides. A specific peptide is included in only one of the horizontal matrix pools (A to J) and only one of the vertical matrix pools (AA to JJ). Therefore, if pools D and CC yield positive responses, peptide 24 triggered the response. If pools C, D, E, and CC induce formation of a significant number of spots in the ELISpot assay, the responsible epitope probably consists of the shared sequence of peptides 23, 24 and 25 (fcsamyvgdl).

Journal: Methods in molecular biology (Clifton, N.J.)

Article Title: Determination of Hepatitis C Virus-Specific T-Cell Activity

doi: 10.1007/978-1-59745-394-3_30

Figure Lengend Snippet: Matrix approach for epitope mapping. In this case, each matrix pool (A to J and AA to JJ) consists of five HCV overlapping peptides. A specific peptide is included in only one of the horizontal matrix pools (A to J) and only one of the vertical matrix pools (AA to JJ). Therefore, if pools D and CC yield positive responses, peptide 24 triggered the response. If pools C, D, E, and CC induce formation of a significant number of spots in the ELISpot assay, the responsible epitope probably consists of the shared sequence of peptides 23, 24 and 25 (fcsamyvgdl).

Article Snippet: Overlapping HCV peptides (OLPs): 15-mer peptides overlapping by 10 amino acids and covering the complete HCV genotype 1 polyprotein sequence (Mimotopes, Raleigh, NC) ( see Note 2 ).

Techniques: Enzyme-linked Immunospot, Sequencing

(A) Breadth of T-cell responses against 23 HIVp24-specific OLPs from VC (N = 19, filled circle) and NC (N = 42, open rectangle) (B) Breadth of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle) (C) Cumulative magnitude of T-cell responses against 23 HIVp24-specific OLPs in VC (N = 19, filled circle) and NC (N = 42, open rectangle) (D) Cumulative magnitude of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle). (E and F) Correlation between breadth and cumulative magnitude of T-cell responses against HIVp24-specific OLPs and patient pVL were analyzed by using Spearman’s rank test.

Journal: PLoS ONE

Article Title: Clinical Outcome of HIV Viraemic Controllers and Noncontrollers with Normal CD4 Counts Is Exclusively Determined by Antigen-Specific CD8 + T-Cell-Mediated HIV Suppression

doi: 10.1371/journal.pone.0118871

Figure Lengend Snippet: (A) Breadth of T-cell responses against 23 HIVp24-specific OLPs from VC (N = 19, filled circle) and NC (N = 42, open rectangle) (B) Breadth of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle) (C) Cumulative magnitude of T-cell responses against 23 HIVp24-specific OLPs in VC (N = 19, filled circle) and NC (N = 42, open rectangle) (D) Cumulative magnitude of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle). (E and F) Correlation between breadth and cumulative magnitude of T-cell responses against HIVp24-specific OLPs and patient pVL were analyzed by using Spearman’s rank test.

Article Snippet: Twenty-three overlapping HIVp24 peptides (OLPs) (20 amino acids long, overlapping by 10 amino acids) and seven previously identified immunodominant epitopes within the HIVp24 protein (accession numbers: JN704002–JN704066) were designed according to a Thai consensus HIV sequence (Mimotope, Australia) [ ].

Techniques:

(A) Functional quality of CD8 + T-cell responses against HIVp24-specific OLPs (N = 23) in VC (N = 18, filled circle) and NC (N = 31, open rectangle) (B) Functional quality of CD8 + T-cell responses against HLA-B*57/B*58-restricted HIVp24-specific epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle). The Y-axis represents absolute CD8 + T cells and the X-axis represents CD8 + T cells with 5-, 4-, 3-, 2-, and 1-function in VC and NC. (C) The correlation between the absolute cell numbers of 5-functional HIVp24-specific CD8 + T cells and pVL was analysed using Spearman’s rank test.

Journal: PLoS ONE

Article Title: Clinical Outcome of HIV Viraemic Controllers and Noncontrollers with Normal CD4 Counts Is Exclusively Determined by Antigen-Specific CD8 + T-Cell-Mediated HIV Suppression

doi: 10.1371/journal.pone.0118871

Figure Lengend Snippet: (A) Functional quality of CD8 + T-cell responses against HIVp24-specific OLPs (N = 23) in VC (N = 18, filled circle) and NC (N = 31, open rectangle) (B) Functional quality of CD8 + T-cell responses against HLA-B*57/B*58-restricted HIVp24-specific epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle). The Y-axis represents absolute CD8 + T cells and the X-axis represents CD8 + T cells with 5-, 4-, 3-, 2-, and 1-function in VC and NC. (C) The correlation between the absolute cell numbers of 5-functional HIVp24-specific CD8 + T cells and pVL was analysed using Spearman’s rank test.

Article Snippet: Twenty-three overlapping HIVp24 peptides (OLPs) (20 amino acids long, overlapping by 10 amino acids) and seven previously identified immunodominant epitopes within the HIVp24 protein (accession numbers: JN704002–JN704066) were designed according to a Thai consensus HIV sequence (Mimotope, Australia) [ ].

Techniques: Functional Assay

(A) In vitro HIV suppression assay mediated by ex vivo unstimulated CD8 + T cells in VC (N = 10, filled circle), NC (N = 10, open rectangle), and healthy volunteers (HD, N = 9, filled triangle) cocultured with autologous HIV-infected CD4 + T cells at E:T ratio of 1:1 at day 7. (B) In vitro HIV suppression assay mediated by HIVp24-specific T cell lines from VC (N = 4, filled circle) and NC (N = 7, open rectangle) cocultured with autologous HIV-infected CD4 + T cells at E:T ratio of 1:1 at day 3. (C) Percentages of ex vivo HIV-infected CD4 + T cells (CD3 pos CD8 neg P24 pos ) in VC (N = 8, filled circle) and NC (N = 13, open rectangle) (D) Production of newly-generated HIV from CD4 + T cells from VC (N = 5, filled circle) and NC (N = 5, open rectangle) at day 7. The Y-axis depicts the concentration of HIVp24 Ag (pg/ml) from ELISA assays. *p value <0.05 and ***p value<0.001.

Journal: PLoS ONE

Article Title: Clinical Outcome of HIV Viraemic Controllers and Noncontrollers with Normal CD4 Counts Is Exclusively Determined by Antigen-Specific CD8 + T-Cell-Mediated HIV Suppression

doi: 10.1371/journal.pone.0118871

Figure Lengend Snippet: (A) In vitro HIV suppression assay mediated by ex vivo unstimulated CD8 + T cells in VC (N = 10, filled circle), NC (N = 10, open rectangle), and healthy volunteers (HD, N = 9, filled triangle) cocultured with autologous HIV-infected CD4 + T cells at E:T ratio of 1:1 at day 7. (B) In vitro HIV suppression assay mediated by HIVp24-specific T cell lines from VC (N = 4, filled circle) and NC (N = 7, open rectangle) cocultured with autologous HIV-infected CD4 + T cells at E:T ratio of 1:1 at day 3. (C) Percentages of ex vivo HIV-infected CD4 + T cells (CD3 pos CD8 neg P24 pos ) in VC (N = 8, filled circle) and NC (N = 13, open rectangle) (D) Production of newly-generated HIV from CD4 + T cells from VC (N = 5, filled circle) and NC (N = 5, open rectangle) at day 7. The Y-axis depicts the concentration of HIVp24 Ag (pg/ml) from ELISA assays. *p value <0.05 and ***p value<0.001.

Article Snippet: Twenty-three overlapping HIVp24 peptides (OLPs) (20 amino acids long, overlapping by 10 amino acids) and seven previously identified immunodominant epitopes within the HIVp24 protein (accession numbers: JN704002–JN704066) were designed according to a Thai consensus HIV sequence (Mimotope, Australia) [ ].

Techniques: In Vitro, HIV Inhibition Assay, Ex Vivo, Infection, Generated, Concentration Assay, Enzyme-linked Immunosorbent Assay

(A) In vitro HIV suppression assay mediated by ex vivo unstimulated CD8 + T cells in culture with autologous CD4 + T cells at various E:T ratios of 1:1 and 0.5:1 in VC (N = 2, filled circle) and NC (N = 3, open rectangle). (B) In vitro HIV suppression assay mediated by HIVp24-specific T cell lines at various E:T ratios of 1:1 and 0.5:1 in VC (N = 2, filled circle) and NC (N = 2, open rectangle).

Journal: PLoS ONE

Article Title: Clinical Outcome of HIV Viraemic Controllers and Noncontrollers with Normal CD4 Counts Is Exclusively Determined by Antigen-Specific CD8 + T-Cell-Mediated HIV Suppression

doi: 10.1371/journal.pone.0118871

Figure Lengend Snippet: (A) In vitro HIV suppression assay mediated by ex vivo unstimulated CD8 + T cells in culture with autologous CD4 + T cells at various E:T ratios of 1:1 and 0.5:1 in VC (N = 2, filled circle) and NC (N = 3, open rectangle). (B) In vitro HIV suppression assay mediated by HIVp24-specific T cell lines at various E:T ratios of 1:1 and 0.5:1 in VC (N = 2, filled circle) and NC (N = 2, open rectangle).

Article Snippet: Twenty-three overlapping HIVp24 peptides (OLPs) (20 amino acids long, overlapping by 10 amino acids) and seven previously identified immunodominant epitopes within the HIVp24 protein (accession numbers: JN704002–JN704066) were designed according to a Thai consensus HIV sequence (Mimotope, Australia) [ ].

Techniques: In Vitro, HIV Inhibition Assay, Ex Vivo